Twist Bioscience (TWST) free cash flow

Free cash flow · fiscal 2026
-$95.96M

Twist Bioscience (TWST) generated free cash flow of -$95.96M in fiscal 2026 (the year ended September 30, 2026). In fiscal 2025 the figure was -$75.63M. Figures as of 18 Nov 2026, 12:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2026
-$95.96M
Highest on record
-$57.90Mfiscal 2017
Lowest on record
-$226.24Mfiscal 2022
Fiscal years on record
102017–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Twist Bioscience free cash flow, in more detail

Across the 10 fiscal years on record (2017–2026), the highest was -$57.90M in fiscal 2017 and the lowest -$226.24M in fiscal 2022.

History · 10 fiscal years

Free cash flow by fiscal year

Twist Bioscience free cash flow, year by year

Twist Bioscience (TWST) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2026-$95.96M—
2025-$75.63M—
2024-$69.17M—
2023-$170.25M—
2022-$226.24M—
2021-$139.31M—
2020-$152.12M—
2019-$102.69M—
2018-$69.85M—
2017-$57.90M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Twist Bioscience and comparable companies
CompanyFree cash flowFiscal year
TG Therapeutics TGTX-$24.99M2025
Praxis Precision Medicines PRAX-$249.12M2025
Twist Bioscience TWST-$95.96M2026
Protagonist Therapeutics PTGX$56.08M2025
Krystal Biotech KRYS$188.91M2025
10x Genomics TXG$130.12M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TWST

Twist Bioscience, figure by figure

Twist Bioscience (TWST) overview: price, valuation and scorecardAll health care companies by market value

Twist Bioscience free cash flow: questions and answers

What is Twist Bioscience's free cash flow?

Twist Bioscience (TWST) generated free cash flow of -$95.96M in fiscal 2026 (the year ended September 30, 2026). In fiscal 2025 the figure was -$75.63M.

What are the highest and lowest free cash flow figures on record for Twist Bioscience?

Across the 10 fiscal years on record (2017–2026), the highest was -$57.90M in fiscal 2017 and the lowest -$226.24M in fiscal 2022.

How is Twist Bioscience's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Twist Bioscience it is on record here for 10 fiscal years, 2017 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Twist Bioscience (TWST) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/TWST/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.